Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 18.77M | 8.06% | $ 232.84M |
3/31/2025 | $ 4.21M | 1.96% | $ 214.71M |
12/31/2024 | $ -187.35M | -5277.55% | $ 3.55M |
9/30/2024 | $ -181.57M | -27890.94% | $ 651K |
6/30/2024 | $ -168.05M | -62012.55% | $ 271K |
3/31/2024 | $ -160.3M | -68505.13% | $ 234K |
12/31/2023 | $ -152.99M | -101319.21% | $ 151K |
9/30/2023 | $ -142.47M | -1780837.5% | $ 8K |
6/30/2023 | $ -126.54M | 0% | $ 0 |
3/31/2023 | $ -116.3M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for KEROS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -45.36M ] / Revenues [ $ 0 ]
(=) Net % [ 0% ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.2K |
---|---|
min | -64.23% |
max | 69.74% |
average | 4.77% |
median | 5.24% |
std | 19.84% |